Scientists deliberately give volunteers strep throat to speed up vaccine development
NCT ID NCT06992141
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This completed early-phase study tested a new way to study Strep A bacteria, which causes strep throat and can lead to serious heart disease. Researchers safely exposed 40 healthy adults aged 18-40 to a specific strain of Strep A under controlled conditions. The goal was to see how much bacteria is needed to cause infection and how the body responds, which could help design better vaccines in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Streptococcus pyogenes M1UK strain MCRI0102
- What this could lead to
- If successful, this study could help researchers develop better vaccines and treatments for Strep A infections, including serious conditions like rheumatic heart disease.
- What could go wrong
- This is a very early, small study with only 40 participants, so results may not apply broadly. There is a risk of infection from the challenge, though it is carefully controlled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STREPTOCOCCUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Doherty Clinical Trials Ltd
Melbourne, Victoria, 3002, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.